Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 141 citing articles:

Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment
Nur Samsu
BioMed Research International (2021) Vol. 2021, pp. 1-17
Open Access | Times Cited: 603
Glomerular hyperfiltration
Monica Cortinovis, Norberto Perico, Piero Ruggenenti, et al.
Nature Reviews Nephrology (2022) Vol. 18, Iss. 7, pp. 435-451
Closed Access | Times Cited: 115
Mechanisms of podocyte injury and implications for diabetic nephropathy
Federica Barutta, Stefania Bellini, Gabriella Gruden
Clinical Science (2022) Vol. 136, Iss. 7, pp. 493-520
Open Access | Times Cited: 115
The cardio-renal-metabolic connection: a review of the evidence
Marella Marassi, Gian Paolo Fadini
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 80
Oxidative Stress: A Culprit in the Progression of Diabetic Kidney Disease
Na Wang, Chun Zhang
Antioxidants (2024) Vol. 13, Iss. 4, pp. 455-455
Open Access | Times Cited: 39
Update on diagnosis, pathophysiology, and management of diabetic kidney disease
Mai Sugahara, Wai Lun Will Pak, Tetsuhiro Tanaka, et al.
Nephrology (2021) Vol. 26, Iss. 6, pp. 491-500
Open Access | Times Cited: 102
Diabetic Nephropathy - a Review of Risk Factors, Progression, Mechanism, and Dietary Management
Natesan Vijayakumar, Sungjin Kim
Biomolecules & Therapeutics (2021) Vol. 29, Iss. 4, pp. 365-372
Open Access | Times Cited: 90
The Inflammasome in Chronic Complications of Diabetes and Related Metabolic Disorders
Stefano Menini, Carla Iacobini, Martina Vitale, et al.
Cells (2020) Vol. 9, Iss. 8, pp. 1812-1812
Open Access | Times Cited: 72
Protein glycation – biomarkers of metabolic dysfunction and early-stage decline in health in the era of precision medicine
Naila Rabbani, Paul J. Thornalley
Redox Biology (2021) Vol. 42, pp. 101920-101920
Open Access | Times Cited: 72
Mitochondria in Diabetic Kidney Disease
Amna Ayesha Ahmad, Shayna Odeal Draves, M. Rosca
Cells (2021) Vol. 10, Iss. 11, pp. 2945-2945
Open Access | Times Cited: 70
Gender Differences in Diabetic Kidney Disease: Focus on Hormonal, Genetic and Clinical Factors
Annalisa Giandalia, Alfio Edoardo Giuffrida, Guido Gembillo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5808-5808
Open Access | Times Cited: 67
Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as novel risk markers for diabetic nephropathy in patients with type 2 diabetes
Marwa Jaaban, Almoutassem Billah Zetoune, Sondos Hesenow, et al.
Heliyon (2021) Vol. 7, Iss. 7, pp. e07564-e07564
Open Access | Times Cited: 57
The Bidirectional Link Between Diabetes and Kidney Disease: Mechanisms and Management
Mahendra Kumar, Shah Dev, Muhammad Khalid, et al.
Cureus (2023)
Open Access | Times Cited: 34
Association between triglyceride-glucose index and risk of end-stage renal disease in patients with type 2 diabetes mellitus and chronic kidney disease
Yue-Ming Gao, Weijia Chen, Zhenling Deng, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 23
Molecular insights of diabetic nephropathy and chemical constituents-based treatment approach
Muhammed Amanat, Kanhaiya Lal, Thakur Gurjeet Singh, et al.
Phytochemistry Reviews (2025)
Closed Access | Times Cited: 1
Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes
Sascha Pilemann-Lyberg, Tine W. Hansen, Nete Tofte, et al.
Diabetes Care (2019) Vol. 42, Iss. 6, pp. 1088-1094
Open Access | Times Cited: 67
Targeting oxidative stress and anti-oxidant defence in diabetic kidney disease
Jakob Appel Østergaard, Mark E. Cooper, Karin Jandeleit‐Dahm
Journal of Nephrology (2020) Vol. 33, Iss. 5, pp. 917-929
Closed Access | Times Cited: 58
Survival and analysis of predictors of mortality in patients undergoing replacement renal therapy: a 20-year cohort
Emily de Souza Ferreira, Tiago Ricardo Moreira, Rodrigo Gomes da Silva, et al.
BMC Nephrology (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 54
Significance of Metformin Use in Diabetic Kidney Disease
Daiji Kawanami, Yuichi Takashi, Makito Tanabe
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4239-4239
Open Access | Times Cited: 51
Optimal Early Diagnosis and Monitoring of Diabetic Kidney Disease in Type 2 Diabetes Mellitus: Addressing the Barriers to Albuminuria Testing
Elena A. Christofides, Niraj Desai
Journal of Primary Care & Community Health (2021) Vol. 12
Open Access | Times Cited: 46
Six-Month Periodic Fasting in Patients With Type 2 Diabetes and Diabetic Nephropathy: A Proof-of-Concept Study
Alba Sulaj, Stefan Kopf, Ekaterina von Rauchhaupt, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 8, pp. 2167-2181
Open Access | Times Cited: 37
Dyslipidemia and serum cystatin C levels as biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus
Tadesse Asmamaw Dejenie, Endeshaw Chekol Abebe, Misganaw Asmamaw Mengstie, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 21
Barriers to initiating SGLT2 inhibitors in diabetic kidney disease: a real-world study
Su Jin Jeong, Seung Eun Lee, Dong Hyun Shin, et al.
BMC Nephrology (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 38
Kidney Biopsy in Type 2 Diabetic Patients: Critical Reflections on Present Indications and Diagnostic Alternatives
Domenico Santoro, Massimo Torreggiani, Vincenzo Pellicanò, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5425-5425
Open Access | Times Cited: 36
Interaction between Plasma Metabolomics and Intestinal Microbiome in db/db Mouse, an Animal Model for Study of Type 2 Diabetes and Diabetic Kidney Disease
Chenhua Wu, Jingjing Fei, Qing Xu, et al.
Metabolites (2022) Vol. 12, Iss. 9, pp. 775-775
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top